Your browser doesn't support javascript.
loading
Feasibility and reliability of measured glomerular filtration rate with [I125]-iothalamate among young adults with mild-to-moderate cerebral palsy.
Whitney, Daniel G; Oliverio, Andrea L; Kreschmer, Jodi; Bolde, Shannen; Hurvitz, Edward A; Wong, Ka Kit.
Afiliação
  • Whitney DG; Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, United States.
  • Oliverio AL; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States.
  • Kreschmer J; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States.
  • Bolde S; Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
  • Hurvitz EA; Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, United States.
  • Wong KK; Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, United States.
Front Med (Lausanne) ; 11: 1295104, 2024.
Article em En | MEDLINE | ID: mdl-38933110
ABSTRACT

Objective:

Despite the need, measuring glomerular filtration rate (mGFR) is not routinely performed for adults with cerebral palsy (CP), possibly due to unknown feasibility given the secondary complications of CP. This study aimed to assess the feasibility and reliability of mGFR and explore factors associated with eGFR-mGFR discordance among young adults with mild-to-moderate CP.

Methods:

This single-center, cross-sectional study included 18- to 40-year-olds with CP gross motor function classification system (GMFCS) I-III. The participants were excluded if they were pregnant/lactating, had cognitive impairments, or had contraindications to mGFR. A routine clinical protocol for mGFR and eGFR was used. mGFR feasibility was assessed based on the number of participants who completed testing. mGFR reliability was assessed using the coefficient of variation (CV) across the four 30 min intervals. The association between age, sex, and GMFCS and the percentage of eGFR-mGFR discordance was assessed.

Results:

Of the 19 participants enrolled, 18 completed the testing [mean age (SD), 29.9 (7.4) years, n = 10 female participants, n = 10/3/5 for GMFCS I/II/III] and most (n = 15) of the participants had an mGFR >90 mL/min; 14 participants (77.8%) had a CV <20%, 2 had a CV between 20 and 25%, and 2 had a CV >50%. eGFR overestimated mGFR by a median (interquartile range) of approximately 17.5% (2-38%); the full range of mis-estimation was -20.5 to 174.3%. Increasing age and GMFCS levels exhibited notable, but weak-to-modest, associations with a larger eGFR-mGFR discordance.

Discussion:

Obtaining mGFR was feasible and reasonably reliable within this small sample. eGFR overestimated mGFR by a notable amount, which may be associated with patient-level factors.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article